Microbiome GLP-1 Receptor Agonists Have Minimal Impact on Obesity-Related Cancer RiskBy adminDecember 11, 20250 Credit: CIPhotos / iStock / Getty Images Plus An analysis of nearly 50 randomized controlled trials has found no link…
Microbiome GLP-1 Agonists May Protect Against Bone Fracture RiskBy adminDecember 10, 20250 Credit: selvanegra/ Getty Images Research led by National Cheng Kung University, Taiwan, suggests glucagon-like peptide 1 (GLP-1) receptor agonists can…
Microbiome GLP-1 Agonists May Alter Cancer Patients’ Scan FindingsBy adminOctober 8, 20250 Credit: JDawnInk /Getty Images The growing use of GLP-1 receptor agonists may affect cancer patients’ care because the drugs can…
DNA & Genetics Examining Alternative Effects of GLP-1 Receptor AgonistsBy adminSeptember 13, 20250 GLP-1 mimicking molecules are increasingly relevant tools in metabolic, cardiovascular, and neurologic preclinical research.©iStock, CIPhotosOver the past two decades, the…
